- Stevanato Group ( NYSE: STVN ) collaborates with Transcoject for adding cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) PFS to its existing portfolio of solutions providing added value in the customers’ supply chain.
- Transcoject is a medical device and pharma packaging solutions company.
- “With this cooperation we combine the strengths of the two companies by bringing together complementary fields of technologies. We thereby intend to strengthen agility and flexibility in terms of customers benefit. In addition, we expect this collaboration to foster innovation and increase value for our customers. I believe this partnership will strengthen our ability to offer our customers outstanding pharma packaging solutions”, emphasized Dr. Christian von Falkenhausen, CEO of Transcoject GmbH.
For further details see:
Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma